OraSure Technologies (NASDAQ:OSUR) Rating Lowered to "Hold" at StockNews.com

OraSure Technologies (NASDAQ:OSUR - Get Free Report) was downgraded by equities research analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued to investors on Thursday.

OraSure Technologies Trading Up 1.0 %

NASDAQ OSUR traded up $0.04 on Thursday, reaching $3.93. The company's stock had a trading volume of 356,731 shares, compared to its average volume of 831,436. The firm has a market cap of $293.14 million, a PE ratio of 26.20 and a beta of 0.05. The business has a 50-day moving average price of $3.81 and a 200 day moving average price of $4.04. OraSure Technologies has a 52 week low of $3.52 and a 52 week high of $8.04.

Institutional Trading of OraSure Technologies

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC boosted its position in OraSure Technologies by 202.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 5,234 shares in the last quarter. Causeway Capital Management LLC acquired a new position in OraSure Technologies in the fourth quarter valued at about $36,000. Raymond James Financial Inc. acquired a new position in OraSure Technologies in the fourth quarter valued at about $37,000. Boothbay Fund Management LLC acquired a new position in OraSure Technologies in the fourth quarter valued at about $42,000. Finally, Atom Investors LP acquired a new position in OraSure Technologies in the third quarter valued at about $49,000. Institutional investors own 93.50% of the company's stock.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.